CN102973918B - 一种治疗肾炎的中药 - Google Patents
一种治疗肾炎的中药 Download PDFInfo
- Publication number
- CN102973918B CN102973918B CN201210546952.4A CN201210546952A CN102973918B CN 102973918 B CN102973918 B CN 102973918B CN 201210546952 A CN201210546952 A CN 201210546952A CN 102973918 B CN102973918 B CN 102973918B
- Authority
- CN
- China
- Prior art keywords
- grams
- fructus
- kidney
- semen
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 201000008383 nephritis Diseases 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 title abstract description 24
- 210000000582 semen Anatomy 0.000 claims abstract description 25
- 241000005787 Cistanche Species 0.000 claims abstract description 6
- 210000001320 hippocampus Anatomy 0.000 claims abstract description 6
- 210000003899 penis Anatomy 0.000 claims abstract description 6
- 241000965254 Apostichopus japonicus Species 0.000 claims description 5
- 210000001550 testis Anatomy 0.000 claims description 5
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 claims description 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 3
- 241001446509 Psoralea Species 0.000 claims description 3
- 241001312519 Trigonella Species 0.000 claims description 3
- 239000010271 massa medicata fermentata Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- 241000251511 Holothuroidea Species 0.000 abstract 1
- 240000007049 Juglans regia Species 0.000 abstract 1
- 235000009496 Juglans regia Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 244000250129 Trigonella foenum graecum Species 0.000 abstract 1
- 229910052891 actinolite Inorganic materials 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000001917 trigonella foenum graecum l. absolute Substances 0.000 abstract 1
- 235000020234 walnut Nutrition 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 48
- 210000004185 liver Anatomy 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 16
- 235000009508 confectionery Nutrition 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 10
- 238000010792 warming Methods 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 208000006750 hematuria Diseases 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 230000008093 supporting effect Effects 0.000 description 5
- 208000037157 Azotemia Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010001580 Albuminuria Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 208000031975 Yang Deficiency Diseases 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 2
- 201000010000 Agranulocytosis Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 206010010075 Coma hepatic Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010018366 Glomerulonephritis acute Diseases 0.000 description 2
- 206010018687 Granulocytopenia Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000019025 Hypokalemia Diseases 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 2
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 206010061372 Streptococcal infection Diseases 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- 231100000851 acute glomerulonephritis Toxicity 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000024924 glomerular filtration Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 201000001059 hepatic coma Diseases 0.000 description 2
- 208000007386 hepatic encephalopathy Diseases 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000024896 potassium deficiency disease Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 2
- 229960003147 reserpine Drugs 0.000 description 2
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 241001517488 Clavus Species 0.000 description 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 102000016918 Complement C3 Human genes 0.000 description 1
- 108010028780 Complement C3 Proteins 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 241000208011 Digitalis Species 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000027776 Extrapyramidal disease Diseases 0.000 description 1
- 206010015993 Eyelid oedema Diseases 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000037147 Hypercalcaemia Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010021027 Hypomagnesaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
- 206010037128 Pseudomembranous colitis Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010041277 Sodium retention Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003460 anti-nuclear Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 235000019564 dysgeusia Nutrition 0.000 description 1
- 208000024732 dysthymic disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 208000022182 gross hematuria Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229960002003 hydrochlorothiazide Drugs 0.000 description 1
- 230000000148 hypercalcaemia Effects 0.000 description 1
- 208000030915 hypercalcemia disease Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000001024 intrahepatic cholestasis Diseases 0.000 description 1
- 230000007872 intrahepatic cholestasis Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000009592 kidney function test Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 210000002990 parathyroid gland Anatomy 0.000 description 1
- 208000025061 parathyroid hyperplasia Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 208000002440 photoallergic dermatitis Diseases 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 238000009603 uroscopy Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210546952.4A CN102973918B (zh) | 2012-12-17 | 2012-12-17 | 一种治疗肾炎的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210546952.4A CN102973918B (zh) | 2012-12-17 | 2012-12-17 | 一种治疗肾炎的中药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102973918A CN102973918A (zh) | 2013-03-20 |
CN102973918B true CN102973918B (zh) | 2014-10-22 |
Family
ID=47848453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210546952.4A Expired - Fee Related CN102973918B (zh) | 2012-12-17 | 2012-12-17 | 一种治疗肾炎的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102973918B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1175447A (zh) * | 1997-07-10 | 1998-03-11 | 迟经惠 | 肾病针剂康 |
CN101670076A (zh) * | 2009-10-30 | 2010-03-17 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗慢性肾炎病证的中药组合物及其制备方法 |
CN102451404A (zh) * | 2010-10-21 | 2012-05-16 | 高菲 | 一种治疗慢性肾炎的中药药方的制备方法 |
-
2012
- 2012-12-17 CN CN201210546952.4A patent/CN102973918B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1175447A (zh) * | 1997-07-10 | 1998-03-11 | 迟经惠 | 肾病针剂康 |
CN101670076A (zh) * | 2009-10-30 | 2010-03-17 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗慢性肾炎病证的中药组合物及其制备方法 |
CN102451404A (zh) * | 2010-10-21 | 2012-05-16 | 高菲 | 一种治疗慢性肾炎的中药药方的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102973918A (zh) | 2013-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102813798B (zh) | 一种治疗热毒型急性肾小球肾炎的中药制备方法 | |
CN102805820B (zh) | 一种治疗咳嗽型急性肾小球肾炎的中药制备方法 | |
CN102793902B (zh) | 一种治疗肾阴亏虚型急性肾小球肾炎的中药制备方法 | |
CN102793903B (zh) | 一种治疗肾阳虚型急性肾小球肾炎的中药制备方法 | |
CN102813757B (zh) | 一种治疗腰痛型急性肾小球肾炎的中药制备方法 | |
CN102813849B (zh) | 一种治疗喘促型急性肾小球肾炎的中药制备方法 | |
CN102813837B (zh) | 一种治疗血压增高型急性肾小球肾炎的中药制备方法 | |
CN102973918B (zh) | 一种治疗肾炎的中药 | |
CN102805851B (zh) | 一种治疗气虚型急性肾小球肾炎的中药制备方法 | |
CN102813771A (zh) | 一种治疗水肿型急性肾小球肾炎的中药制备方法 | |
CN104666689A (zh) | 一种治疗高血压的药物 | |
CN102813897B (zh) | 一种治疗不寐型急性肾小球肾炎的中药制备方法 | |
CN102805850B (zh) | 一种治疗疲乏型急性肾小球肾炎的中药制备方法 | |
CN102813822B (zh) | 一种治疗疼痛型急性肾小球肾炎的中药制备方法 | |
CN102793866B (zh) | 一种治疗足部水肿型急性肾小球肾炎的中药制备方法 | |
CN102784376B (zh) | 一种治疗纳呆型急性肾小球肾炎的中药制备方法 | |
CN102813785B (zh) | 一种治疗头痛型急性肾小球肾炎的中药制备方法 | |
CN102813848B (zh) | 一种治疗呕吐型急性肾小球肾炎的中药制备方法 | |
CN102813784B (zh) | 一种治疗血尿型急性肾小球肾炎的中药制备方法 | |
CN102813880B (zh) | 一种治疗瘀血型急性肾小球肾炎的中药制备方法 | |
CN102784320B (zh) | 一种治疗尿色黄浊型急性肾小球肾炎的中药制备方法 | |
CN102805853B (zh) | 一种治疗蛋白尿型急性肾小球肾炎的中药制备方法 | |
CN102813895B (zh) | 一种治疗嗜睡型急性肾小球肾炎的中药制备方法 | |
CN102813896B (zh) | 一种治疗寒冷敏感型急性肾小球肾炎的中药制备方法 | |
CN102813846B (zh) | 一种治疗高脂型急性肾小球肾炎的中药制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO WINCHANCE TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: QINGDAO HUADIAN HIGH VOLTAGE ELECTRIC CO., LTD. Effective date: 20140919 |
|
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Su Jianli Inventor before: Zhang Ligang Inventor before: Qu Jian Inventor before: Zhang Lei Inventor before: Wu Gang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG LIGANG QU JIAN ZHANG LEI WU GANG TO: SU JIANLI Free format text: CORRECT: ADDRESS; FROM: 266101 QINGDAO, SHANDONG PROVINCE TO: 266061 QINGDAO, SHANDONG PROVINCE |
|
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140919 Address after: 266061 Shandong, Laoshan, Hongkong East Road, No. Pioneering Park, biological park, room 248, No. 239 Applicant after: Qingdao Wenchuang Science & Technology Co., Ltd. Address before: 266101, No. nine, No. 628 East water road, Laoshan District, Shandong, Qingdao Applicant before: Qingdao Huadian High Voltage Electric Co., Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Yan Inventor before: Su Jianli |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170224 Address after: 150000 Lanxi County, Heilongjiang Xinmin community West Road, the people's livelihood Lane 01, No. three Patentee after: Liu Yan Address before: 266061 Shandong, Laoshan, Hongkong East Road, No. Pioneering Park, biological park, room 248, No. 239 Patentee before: Qingdao Wenchuang Science & Technology Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141022 Termination date: 20181217 |